#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteomyelitis Henoch-Schonlein purpura Methylmalonic acidaemia Extra-osseous Ewing's sarcoma recurrent Proteus syndrome Arteriosclerosis Chorioretinitis Glomerulonephritis chronic Retinitis pigmentosa Non-Hodgkin's lymphoma refractory Ventricular fibrillation Myxofibrosarcoma Heart disease congenital Cryoglobulinaemia Chondrosarcoma More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic – Basic Information X-linked lymphoproliferative syndrome – Life with Disease Breast angiosarcoma metastatic Paraneoplastic neurological syndrome Lennox-Gastaut syndrome – Life with Disease Burkitt’s lymphoma – Basic Information Mantle cell lymphoma – Life with Disease Hepatoblastoma Crigler-Najjar syndrome – Diagnostics Shprintzen-Goldberg syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apitegromab Arrhenatherum Elatius Argatroban Monohydrate Lib-01 Monohydrate Copanlisib Dihydrochloride Losartan Belantamab Mafodotin Colchicine Mva-Hbvac EGANELISIB Tivozanib Pralatrexate MB-CART2219.1 Itepekimab Sodium Butyrate Rbp030.2 Azelastine Surzebiclimab Pf-06835375 Levamlodipine Succinate More therapies…

    Learn about Your Condition

    Essential thrombocythaemia Mental disorder Eyelid ptosis Mucous membrane pemphigoid Cough Metastasis Obstructive pancreatitis Genital herpes simplex Postoperative delirium Liposarcoma metastatic Pleural mesothelioma Impaired gastric emptying Oxygen saturation Rectal neoplasm Mitochondrial myopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Prophylaxis against transplant rejection

  • Study on Siplizumab, Cyclophosphamide, and Splenectomy for Preventing Liver Transplant Rejection in Patients Receiving a Deceased Donor Liver

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Siplizumab
    Sweden

  • Long-Term Follow-Up Study of TX200-TR101 for Patients with Kidney Transplant Rejection

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tx200-Tr101
    Belgium The Netherlands

  • Study Comparing Tacrolimus Formulations for Preventing Liver Transplant Rejection in New Adult Recipients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tacrolimus
    Germany

  • Study on Siplizumab and Rabbit Anti-Thymocyte Globulin for Preventing Rejection in New Kidney Transplant Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Siplizumab
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    Austria Spain Sweden

  • Study on the Safety of TX200-TR101 for Preventing Kidney Transplant Rejection in Patients Receiving a Living Donor Transplant

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Tx200-Tr101
    Belgium The Netherlands

  • Study Comparing Tacrolimus Levels in Children with Organ Transplants Switching from Prograf to Advagraf

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Tacrolimus
    Czechia
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!